Clinical trial · Observational
Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment
Evaluation of Liver Function Test to Identify Hepatotoxcicity Among Acute Leukemia Patients Who Are Receiving Chemotherapy Induction
NCT06383325CI-TRIAL-00076484unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Detection of hepatotoxcicity in acute leukemia and study the outcome of acute leukemia patients that suffer from hepatic toxiciyt
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Toxicity, Chemically-Induced | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Detection of hepatotoxcicity in acute leukemia during chemotherapy treatment
- timeFrame
- 3 months
- description
- Evaluation of liver function test to identfy hepatotoxicity during chemotherapy treatment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * patients newly diagnosed with acute leukemia who are going to start chemotherapy treatment Exclusion Criteria: * patients previously diagnosed Acute leukemia and started treatment or in post treatment follow up
References
Publications (1)
- BACKGROUNDMekonnen AT, Wondmeneh TG. Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction. Sci Rep. 2022 Aug 2;12(1):13215. doi: 10.1038/s41598-022-17618-w. PMID 35918381